Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Feldman

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Journal of Developmental and Behavioral Pediatrics : JDBP|March 5, 2002
Confessions of a managed behavioral health care physicianSteven A Feldman
Endocrine Pathology|May 15, 2003
The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasiaSteven A Feldman, Lee E Eiden
Journal of Virology|November 5, 2002
Host range and receptor binding properties of vectors bearing feline leukemia virus subgroup B envelopes can be modulated by envelope sequences outside of the receptor binding domainPeggy Ho Faix, Steven A Feldman, Julie Overbaugh, et al.
Journal of Virology|October 20, 2006
Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivityRoberta L Crim, Susette A Audet, Steven A Feldman, et al.
Journal of Virology|December 25, 2003
Identification of an extracellular domain within the human PiT2 receptor that is required for amphotropic murine leukemia virus bindingSteven A Feldman, Karen B Farrell, Ravi K Murthy, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 13, 2011
Augmented lymphocyte expansion from solid tumors with engineered cells for costimulatory enhancementKevin M Friedman, Laura E Devillier, Steven A Feldman, et al.
Journal of Immunological Methods|January 25, 2011
Development of a genetically-modified novel T-cell receptor for adoptive cell transfer against renal cell carcinomaQiong J Wang, Ken-ichi Hanada, Steven A Feldman, et al.
Trends in Cancer|April 13, 2023
Neoantigen-directed therapeutics in the clinic: where are we?Lien Lybaert, Kris Thielemans, Steven A Feldman, et al.
Human Gene Therapy Methods|November 30, 2016
A Rapid Cell Expansion Process for Production of Engineered Autologous CAR-T Cell TherapiesTangying Lily Lu, Omar Pugach, Robert Somerville, et al.
Plos One|April 1, 2014
Development of a T cell receptor targeting an HLA-A*0201 restricted epitope from the cancer-testis antigen SSX2 for adoptive immunotherapy of cancerDaniel Abate-Daga, Daniel E Speiser, Nachimuthu Chinnasamy, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Journal of Developmental and Behavioral Pediatrics : JDBP|March 5, 2002
Confessions of a managed behavioral health care physicianSteven A Feldman
Endocrine Pathology|May 15, 2003
The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasiaSteven A Feldman, Lee E Eiden
Journal of Virology|November 5, 2002
Host range and receptor binding properties of vectors bearing feline leukemia virus subgroup B envelopes can be modulated by envelope sequences outside of the receptor binding domainPeggy Ho Faix, Steven A Feldman, Julie Overbaugh, et al.
Journal of Virology|October 20, 2006
Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivityRoberta L Crim, Susette A Audet, Steven A Feldman, et al.
Journal of Virology|December 25, 2003
Identification of an extracellular domain within the human PiT2 receptor that is required for amphotropic murine leukemia virus bindingSteven A Feldman, Karen B Farrell, Ravi K Murthy, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 13, 2011
Augmented lymphocyte expansion from solid tumors with engineered cells for costimulatory enhancementKevin M Friedman, Laura E Devillier, Steven A Feldman, et al.
Journal of Immunological Methods|January 25, 2011
Development of a genetically-modified novel T-cell receptor for adoptive cell transfer against renal cell carcinomaQiong J Wang, Ken-ichi Hanada, Steven A Feldman, et al.
Trends in Cancer|April 13, 2023
Neoantigen-directed therapeutics in the clinic: where are we?Lien Lybaert, Kris Thielemans, Steven A Feldman, et al.
Human Gene Therapy Methods|November 30, 2016
A Rapid Cell Expansion Process for Production of Engineered Autologous CAR-T Cell TherapiesTangying Lily Lu, Omar Pugach, Robert Somerville, et al.
Plos One|April 1, 2014
Development of a T cell receptor targeting an HLA-A*0201 restricted epitope from the cancer-testis antigen SSX2 for adoptive immunotherapy of cancerDaniel Abate-Daga, Daniel E Speiser, Nachimuthu Chinnasamy, et al.
Pageof 7